We are live on ! Find out more
DMK

David M. Knott Portfolio holdings

AUM $275M
1-Year Est. Return 59.23%
This Fund
S&P 500
This Quarter Est. Return
+6.72%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
–
AUM
$281M
AUM Growth
+$47.6M
Cap. Flow
+$23.4M
Cap. Flow %
8.3%
Top 10 Hldgs %
45.9%
Holding
164
New
35
Increased
26
Reduced
12
Closed
17

Top Buys

Rank Stock Value
1
MITAU
Coliseum Acquisition Corp. Unit
MITAU
+$14.7M
2
PSTH
Pershing Square Tontine Holdings, Ltd.
PSTH
+$6.6M
3
FAZE
FaZe Holdings Inc. Common Stock
FAZE
+$5.13M
4
TWLV
Twelve Seas Investment Company II Class A Common Stock
TWLV
+$4.99M
5
GLHA
Glass Houses Acquisition Corp. Class A common stock
GLHA
+$4.83M

Top Sells

Rank Stock Value
1
AGAC.U
African Gold Acquisition Corp Units
AGAC.U
+$6.11M
2
TWLVU
Twelve Seas Investment Company II Unit
TWLVU
+$5.07M
3
GLHAU
Glass Houses Acquisition Corp. Unit
GLHAU
+$5.01M
4
LOKM.U
Live Oak Mobility Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-fifth of one warrant
LOKM.U
+$3.59M
5
DOMA
Doma Holdings, Inc.
DOMA
+$2.52M

Sector Composition

Rank Sector Weight
1 Financials 27.9%
2 Healthcare 23.27%
3 Miscellaneous 14.09%
4 Materials 10.3%
5 Communication Services 8.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTVA icon
76
Corteva
CTVA
$56B
$534K 0.19%
12,033
– –
MIC
77
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$503K 0.18%
13,150
– –
WPC icon
78
W.P. Carey
WPC
$16.1B
$448K 0.16%
6,126
– –
TIGR
79
UP Fintech Holding
TIGR
$906M
$398K 0.14%
13,736
– –
MSFT icon
80
Microsoft
MSFT
$3.81T
$379K 0.13%
1,400
– –
CAG icon
81
Conagra Brands
CAG
$7.72B
$364K 0.13%
10,000
– –
GMED icon
82
Globus Medical
GMED
$11.1B
$359K 0.13%
4,631
– –
TARA icon
83
Protara Therapeutics
TARA
$226M
$352K 0.13%
36,164
+21,795
+152% +$247K
ALIM
84
DELISTED
Alimera Sciences
ALIM
$348K 0.12%
38,226
-19,882
-34% -$195K
IBER
85
DELISTED
Ibere Pharmaceuticals
IBER
$348K 0.12%
+36,000
New +$350K
META icon
86
Meta Platforms (Facebook)
META
$1.47T
$344K 0.12%
990
– –
CRSP icon
87
CRISPR Therapeutics
CRSP
$5.58B
$324K 0.12%
+2,000
New +$243K
JMIA
88
Jumia Technologies
JMIA
$865M
$297K 0.11%
9,800
+4,100
+72% +$124K
PSTX
89
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$296K 0.11%
29,566
– –
AAPL icon
90
Apple
AAPL
$4.67T
$288K 0.1%
2,100
– –
QTEKW
91
DELISTED
QualTek Services Inc. Warrant
QTEKW
$288K 0.1%
+25,000
New +$27.1K
MSACW
92
DELISTED
Medicus Sciences Acquisition Corp. Warrant
MSACW
$256K 0.09%
+22,222
New +$17.6K
FSBW icon
93
FS Bancorp
FSBW
$337M
$255K 0.09%
7,154
– –
WARR
94
DELISTED
Warrior Technologies Acquisition Company
WARR
$242K 0.09%
+25,000
New +$243K
PRGO icon
95
Perrigo
PRGO
$2.01B
$225K 0.08%
+4,915
New +$218K
SIOX
96
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$218K 0.08%
80,000
+10,000
+14% +$24.9K
IBER.WS
97
DELISTED
Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
IBER.WS
$207K 0.07%
+18,000
New +$10.9K
RLMD icon
98
Relmada Therapeutics
RLMD
$462M
$192K 0.07%
6,000
+3,000
+100% +$104K
SEEL
99
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$191K 0.07%
19
– –
SSB icon
100
SouthState Bank Corp
SSB
$10.3B
$171K 0.06%
2,082
– –
2 3
4
5 6

Similar funds

FA
FMA Advisory Harrisburg, Pennsylvania $268M AUM 30.8% 1-Year Est. Return
KCP
KDI Capital Partners Raleigh, North Carolina $290M AUM 26.07% 1-Year Est. Return
HCIA
Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return
ISG
Investment Security Group Denver, Colorado $252M AUM 28.26% 1-Year Est. Return
TPCM
Three Peaks Capital Management Castle Rock, Colorado $301M AUM 43.39% 1-Year Est. Return
DCM
DeGreen Capital Management Scottsdale, Arizona $301M AUM 17.24% 1-Year Est. Return
MCL
MIK Capital LP New York $247M AUM 78.02% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return

David M. Knott's Q2 2021 Portfolio in Review

As of Q2 2021, David M. Knott held 164 positions worth $281M, up 20% from $234M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

David M. Knott deployed $23.4M of net new capital in Q2 2021, opening 35 new positions and adding to 26 existing holdings. Its largest new stake was Coliseum Acquisition Corp. Unit: 1,485,000 shares worth $14.7M.

By sector, the portfolio is most concentrated in Financials at 28% of assets, up from 23% a quarter earlier, followed by Healthcare and Miscellaneous.

On the sell side, the largest reduction was Gilead Sciences, an estimated $2.37M trimmed.

  • David M. Knott's largest Q2 2021 buy was Coliseum Acquisition Corp. Unit: 1,485,000 shares worth $14.7M.
  • David M. Knott added most to Calumet Specialty Products in Q2 2021, an estimated $1.9M increase.
  • David M. Knott's biggest Q2 2021 reduction was Gilead Sciences, cutting an estimated $2.37M.
  • David M. Knott fully exited African Gold Acquisition Corp Units in Q2 2021, selling an estimated $6.11M.
  • David M. Knott's ten largest holdings make up 46% of its $281M portfolio in Q2 2021.
  • David M. Knott opened 35 new positions and closed 17 in Q2 2021.
  • David M. Knott's portfolio value rose 20% quarter-over-quarter to $281M.

Based on David M. Knott's 13F filing for Q2 2021, filed 13 Aug 2021.